BSR has published an updated life-course guideline for the prescription and monitoring of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs). Find out more via our blog. Join guideline working group Chair, Louise Mercer, and group members James Galloway, Katie Bechman, Akhila Kavirayani and Alan Davidson, in a roundtable discussion hosted by Prof Ernest Choy, Editor in Chief of Rheumatology to find out what is included in the publication and what has changed since ...
All content for Talking Rheumatology is the property of British Society for Rheumatology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
BSR has published an updated life-course guideline for the prescription and monitoring of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs). Find out more via our blog. Join guideline working group Chair, Louise Mercer, and group members James Galloway, Katie Bechman, Akhila Kavirayani and Alan Davidson, in a roundtable discussion hosted by Prof Ernest Choy, Editor in Chief of Rheumatology to find out what is included in the publication and what has changed since ...
Ep 24. INNOVATORS - Pioneering cost-effective biologics prescribing with a shared decision making tool
Talking Rheumatology
33 minutes
1 year ago
Ep 24. INNOVATORS - Pioneering cost-effective biologics prescribing with a shared decision making tool
Can a new web tool drive shared decision making and cost effective biologics prescribing across NHS trusts?In this episode of our Innovators mini-series, Emily Rose-Parfitt and Philip Hamann join Lizzy MacPhie to showcase the truly pioneering RxInvolve web tool, which aids shared and clinical decision making for biologics prescribing. With patient feedback indicating high satisfaction, plus cost savings of over £200K for North Bristol NHS Trust in its first year of use, development of the too...
Talking Rheumatology
BSR has published an updated life-course guideline for the prescription and monitoring of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs). Find out more via our blog. Join guideline working group Chair, Louise Mercer, and group members James Galloway, Katie Bechman, Akhila Kavirayani and Alan Davidson, in a roundtable discussion hosted by Prof Ernest Choy, Editor in Chief of Rheumatology to find out what is included in the publication and what has changed since ...
